Clinical Trials · NCT00740831
PGL4001 Versus GnRH-agonist in Uterine Myomas
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- PregLem SA
- Enrollment
- 301
- Start date
- Aug 2008
- Locations
- 46 sites, 9 countries
- Primary endpoint
- Percentage of Subjects With Reduction of Uterine Bleeding at Week 13 Visit Defined as Pictorial Blood-loss Assessment Chart (PBAC) Score < 75 at End-of-treatment Visit (Week 13 Visit)